12172983Park DK, Ryan CW, Dolan ME, Vogelzang NJ, Stadler WMCancer chemotherapy and pharmacologyAntineoplastic Agents, Alkylating; Carcinoma, Renal Cell; Dacarbazine; Kidney Neoplasms; Salvage TherapyAged; Biomarkers, Tumor; Drug Resistance, Neoplasm; Female; Humans; Life Tables; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Proteins; O(6)-Methylguanine-DNA Methyltransferase; Survival Analysis; Temozolomide; Treatment FailureA phase II trial of oral temozolomide in patients with metastatic renal cell cancer. Cancer Chemother Pharmacol. 2002 Aug; 50(2):160-2.Cancer Chemother Pharmacol2002-07-05T00:00:002002A phase II trial of oral temozolomide in patients with metastatic renal cell cancer.prns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkAnchorTextlink anchor textvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000368Living Beings1341183530.29479AgedD002292Disorders1134250.717118Carcinoma, Renal CellD003606Chemicals & Drugs441020.937012DacarbazineD007680Disorders1406200.652846Kidney NeoplasmsAuthorship 210865Authorship 210873D008875Concepts & IdeasLiving Beings1473249570.258834Middle AgedD005260Physiology1992444050.191184FemaleD006801Living Beings2262862810.130064HumansD014408Chemicals & Drugs32614610.548135Biomarkers, TumorD008297Physiology1931408600.201635MaleD019008Physiology1805890.751147Drug Resistance, Neoplasm0.2217020.05542552authors10.2518has subject areaMedicine-Hematology and OncologyD016879Procedures972320.889684Salvage TherapyD009362Disorders26910560.715996Neoplasm MetastasisD018906Chemicals & Drugs651380.92013Antineoplastic Agents, AlkylatingD015993Activities & BehaviorsConcepts & Ideas33480.99324Life TablesD016019Concepts & Ideas43415360.742939Survival AnalysisD017211Concepts & Ideas1712840.927981Treatment FailureD019853Chemicals & Drugs221180.961643O(6)-Methylguanine-DNA Methyltransferasehttp://www.pgrn.org/pgx-of-chemotherapeutic-toxicities.htmlMy Lab ObjectivesD009363Chemicals & Drugs2285320.755171Neoplasm ProteinsMedicineUniversity of ChicagoWalter M.StadlerWalter M. Stadler41.78927490000000-87.601250000000001904Stadler, Walter M.ProfessorMary EileenDolan2mdtBK0UF8zMknJtY0fp/Cv/+94=Mary Eileen Dolan41.78927490000000-87.601250000000002594Dolan, Mary EileenProfessortrue1ProfessorProfessortrue1ProfessorProfessor